Q2 2025 Zoetis Inc Earnings Call Transcript
Key Points
- Zoetis Inc (ZTS) reported strong 8% organic operational revenue growth, highlighting the strength of its innovation engine and customer-focused execution.
- The International segment grew organic operational revenue by 9%, demonstrating the company's ability to capitalize on expanding regional markets.
- The Companion Animal segment grew 8% operationally, with the Simparica franchise achieving 17% operational growth, showcasing the company's strong market position.
- Zoetis Inc (ZTS) raised its full-year guidance for organic operational revenue growth to 6.5% to 8%, reflecting confidence in continued strong performance.
- The company has a diversified portfolio with growth across markets, species, franchises, and channels, contributing to its consistent performance and resilience in various market conditions.
- Librela, a product for osteoarthritis pain, declined 7% operationally, with adoption challenges impacting growth expectations.
- The US Livestock segment experienced a 2% organic operational decline, primarily due to timing issues related to supply.
- Zoetis Inc (ZTS) faces competitive pressures in key franchises, including Simparica and Key Dermatology, which could impact future growth.
- The company is navigating a dynamic tariff environment, which could pose challenges to cost management and profitability.
- Despite strong growth in certain segments, the overall reported revenue growth was only 4%, indicating potential headwinds from foreign exchange and divestitures.
Welcome to the second quarter, 2025 financial results conference call and webcast for Zoetis. Hosting the call today is Steven Frank, Vice President of Investor Relations for Zoetis. The presentation materials and additional financial tables are currently posted on the Investor Relations section of Zoettis.com.
The presentation slides can be managed by you, the viewer, and will not be forwarded automatically. In addition, a replay of this call will be available approximately two hours after the conclusion. Via dial-in or on the Investor Relations section of Zoetis.com.
(Operator Instructions)
It is now my pleasure to turn the call over to your host Steven Frank, Vice President of Investor Relations for Zoetis.
Thank you, operator. Good morning, everyone, and welcome to the Zoetis second quarter 2025 earnings call. I am joined today by Kristin Peck, our Chief Executive Officer; and Wetteny Joseph, our Chief Financial Officer.
Before we begin, I'll remind you that the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
